What is specific about $1.71.
While I'd be happy with it, up roughly a million with it, but I don't see it as anything special.
Yesterday I mentioned a company, MLTX, which appears to be in a similar position but whose market cap is about 5 times ours. I believe they're where they should be, it's us who aren't where we should be for a company that's about to have their first product approved. Actually I've never heard of what they're curing, but they are about to file with the FDA, so we're a lot closer. I think we're much closer, but the MM's that are manipulating the stock would like to bankrupt the company. If you read the CEO's profile, you should realize this was a poor bet on their part.
Gary
Market Data 
Markets 
